An Early Phase 1 interventional study of Tranexamic Acid (TXA) intarmuscular and Tranexamic Acid (TXA) intravenous in Blood Loss After a Total Hip Replacement, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-14.
Sponsored by Alexandria University · Early Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Intramuscular vs. Intravenous Tranexamic Acid for Total Hip Arthroplasty
Alexandria University is the lead sponsor of 607 studies on the registry; 142 are open to participants now.
Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1. History of renal failure or kidney transplant. 2. History of an arterial thromboembolic event (such as myocardial infarction or stroke) within the past year.
3. Placement of an arterial stent within the past year. 4. History of deep venous thrombosis (DVT) or pulmonary embolism (PE). 5. Known to tranexamic acid. 6. Pregnancy or breastfeeding. 7. Refusal to participate or refusal to consent to receive blood products.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tranexamic acid 1 gram administered via deep intramuscular injection into the lateral thigh or deltoid muscle prior to surgery. Anesthesia maintained with a balanced inhalational technique (isoflurane 1-1.5% in oxygen-enriched air) and baseline fluid therapy 10 ml per kg per hour of lactated Ringer's solution).
Drug: Tranexamic Acid (TXA) intarmuscular
Tranexamic acid 1 gram administered intravenously over 10 minutes, following standard protocols, prior to surgery. Anesthesia maintained with a balanced inhalational technique (isoflurane 1-1.5% in oxygen-enriched air) and baseline fluid therapy 10 ml per kg per hour of lactated Ringer's solution).
Drug: Tranexamic Acid (TXA) intravenous
Tranexamic acid 1 gram administered via deep intramuscular injection into the lateral thigh or deltoid muscle prior to surgery.
Tranexamic acid 1 gram administered intravenously over 10 minutes, following standard protocols, prior to surgery.
Change of Hemoglobin Concentration
Time frame: From baseline (preoperative) up to hospital discharge (typically 3-5 days postoperatively).
Postoperative Calculated Blood Loss
Volume of total blood loss calculated as a function of patient characteristics (sex, height, weight) and perioperative hemoglobin balance using standard Gross and Nadler mathematical formulas.
Time frame: From day 1 Up to hospital discharge.
Postoperative Calculated Hemoglobin Loss
Total mass of hemoglobin loss calculated based on patient baseline physical parameters and perioperative hemoglobin balance.
Time frame: From day 1 Up to hospital discharge.
Number of Blood Units Transfused
The total cumulative units of blood products administered per patient.
Time frame: From the start of surgery at day 1 up to hospital discharge.
Blood Transfusion Rate
The percentage/proportion of patients requiring allogeneic blood transfusion.
Time frame: From day 1 at the start of surgery up to hospital discharge
Length of Hospital Stay
Total number of days from surgical admission to official hospital discharge
Time frame: Up to 30 days postoperatively.
Incidence of Thromboembolic Events
Frequency of clinical or diagnostic thromboembolic complications (including deep venous thrombosis, pulmonary embolism, myocardial infarction, or stroke
Time frame: Up to 30 days postoperatively.
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tranexamic Acid